Dubai: Kathleen Purificacion Farinas, 28 year old UAE resident reached out to Zulekha Hospital when she experienced fatigue during her daily routine. She was diagnosed with an atrial septal defect a month ago. In such cases, patients can be completely asymptomatic or complain of tiredness on exertion and repeated chest infections.

This congenital defect occurs as a result of early developmental problems in the heart’s structure. The exact cause of this defect in children is unknown but it can run in family. If one or both parents or sibling are affected then there is a high probability of this defect in the child. At times taking certain prescribed drugs and consuming alcohol during pregnancy can increase a child’s risk of developing a heart defect. Mothers who had a viral infection during the first trimester of pregnancy are more likely to give birth to a child with a heart defect, increased blood sugar levels may also affect heart development. Scientists have known that some types of congenital heart defects can be related to an abnormality in the number of an infant's chromosomes or single gene defect.

If left untreated in long term, individuals are at risk of developing high lung pressure, heart failure, infection in the heart, heart rhythm disturbances, a high risk of stroke and sudden death.  

Consultant Pediatric Cardiology Dr. Nilesh Oswal says, “While most cases are treated in childhood, adults also can safely undergo this closure. The treatments are simple and involve one or two hour key-hole procedures, and today there are several different type of devices available in market for the closures. The devices are made of Nitinol, a safe material and have two disks to close the hole. Patients can be mobilized six hours after the surgery and then resume their normal activities.”

Kathleen remarked, “I am very happy with the outcome of the defect closing procedure done at Zulekha Hospital, Dubai. I am breathing more comfortably now and feel lot lighter while performing my daily tasks.”

Consultant Interventional Cardiologist Dr. Anil Bansal who supported the procedure added, “Families of such patients are impacted with a lower quality of life. Patients are generally panicking when one is diagnosed with the opening in his/her heart. They can lead a healthy life with a simple procedure and little caution. We are glad that we are helping Kathleen and similar patients normalize their lives.”

Kathleen is advised to take medicines for thinning blood for six months to prevent developing any blood clots around the device and avoid strenuous exercises for two weeks. Chances of any recurrence are absolutely negligible.

About Zulekha Healthcare Group www.zulekhahospitals.com

 Zulekha Healthcare Group is a Superbrand and among the forerunners in UAE healthcare. Today the Zulekha Healthcare Group includes two multidisciplinary hospitals in Dubai and Sharjah, as well as four UAE medical centres and three pharmacies providing specialised treatments in over 30 disciplines. The group also has a multidisciplinary hospital in India - Alexis. Zulekha Hospital has received extensive recognition for its commitment towards quality care and sustainable business practices, and recently received the prestigious Dubai Quality Award for the second time in four years, underling a commitment to providing high quality healthcare to patients and society.

Media Contact:
Sameena Khanam - Senior Manager PR and Communications
Zulekha Hospitals:  +971 6 5069254 (skhanam@zulekhahospitals.com)

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.